Comparative characteristics of the complement system in patients with C3-glomerulopathy and atypical hemolytic uremic syndrome of chronic course who suffered an acute episode of thrombotic microangiopathy
- 作者: Yurova V.A.1, Kozlovskaya N.L.2, Bobrova L.A.1, Kozlov L.V.3, Andina S.S.3, Demyanova K.A.2
-
隶属关系:
- Sechenov First Moscow State Medical University (Sechenov University)
- People’s Friendship University of Russia (RUDN University)
- Gabrichevsky Research Institute for Epidemiology and Microbiology
- 期: 卷 95, 编号 6 (2023)
- 页面: 475-480
- 栏目: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/133107
- DOI: https://doi.org/10.26442/00403660.2023.06.202269
- ID: 133107
如何引用文章
全文:
详细
Aim. To compare changes in the complement system in C3-glomerulopathy (C3-GP) and atypical hemolytic uremic syndrome (aHUS) after the relief of an acute episode of thrombotic microangiopathy.
Materials and methods. The study included 8 patients diagnosed with C3-GP and 8 with aHUS in remission. The blood levels of the complement system components were determined: C3, C4, C3a, C5a, factor H (CFH), factor B (CFB), membrane-attacking complex (MAC), antibodies to C3b (anti-C3b-AT), the level of hemolytic activity (CH50), the content of factor D (CFD) in the urine.
Results. C3 and CH50 levels were within the reference range in both groups, however, in the C3-GP group they were at the lower limit, and C3 level was significantly lower than in the aHUS group: 0.56 [0.44; 0.96] vs 1.37 [1.16; 2.52] (p=0.003). CFB increased level was detected in both groups, but in the C3-GP group it was significantly lower than in the aHUS group – 275.1 [222.1; 356.6] vs 438.7 [323.3; 449.3] (p=0.010). C3a, C5a and MAC levels were increased in both groups, but the maximum was in the C3-GP group, and the MAC level in the C3-GP group was 2 times higher than that in aHUS, and these differences reached statistical significance – 123 555±6686 vs 5603±1294 (p=0.036). CFH and CFD levels was increased in both groups, but their highest values was in the aHUS group.
Conclusion. Alternative complement pathway activation signs were present in both groups of patients with complement-mediated nephropathies, regardless the stage of the disease. In C3-GP, alternative complement pathway activation was more pronounced than in aHUS after the relief of an acute episode of thrombotic microangiopathy.
作者简介
Valeriya Yurova
Sechenov First Moscow State Medical University (Sechenov University)
编辑信件的主要联系方式.
Email: val84-05@mail.ru
ORCID iD: 0000-0002-7041-3391
ст. лаборант каф. внутренних, профессиональных болезней и ревматологии Института клинической медицины им. Н.М. Склифосовского ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)
俄罗斯联邦, MoscowNatalia Kozlovskaya
People’s Friendship University of Russia (RUDN University)
Email: val84-05@mail.ru
ORCID iD: 0000-0002-4275-0315
д-р мед. наук, проф., проф. каф. внутренних болезней с курсом функциональной диагностики и кардиологии им. В.С. Моисеева ФГАОУ ВО РУДН
俄罗斯联邦, MoscowLarisa Bobrova
Sechenov First Moscow State Medical University (Sechenov University)
Email: val84-05@mail.ru
ORCID iD: 0000-0001-6265-4091
канд. мед. наук, ассистент каф. внутренних, профессиональных болезней и ревматологии Института клинической медицины им. Н.М. Склифосовского ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)
俄罗斯联邦, MoscowLeonid Kozlov
Gabrichevsky Research Institute for Epidemiology and Microbiology
Email: val84-05@mail.ru
д-р биол. наук, проф., ФБУН «МНИИЭМ им. Г.Н. Габричевского»
俄罗斯联邦, MoscowSvetlana Andina
Gabrichevsky Research Institute for Epidemiology and Microbiology
Email: val84-05@mail.ru
ORCID iD: 0000-0002-0284-3787
канд. биол. наук, ст. науч. сотр. ФБУН «МНИИЭМ им. Г.Н. Габричевского»
俄罗斯联邦, MoscowKseniya Demyanova
People’s Friendship University of Russia (RUDN University)
Email: val84-05@mail.ru
ORCID iD: 0000-0001-8927-5841
канд. мед. наук, доц. каф. внутренних болезней с курсом функциональной диагностики и кардиологии им. В.С. Моисеева ФГАОУ ВО РУДН
俄罗斯联邦, Moscow参考
- Noris M, Remuzzi G. Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015. Am J Kidney Dis. 2015;66(2):359-75. doi: 10.1053/j.ajkd.2015.03.040
- Cook HT. Evolving complexity of complement-related diseases: C3 glomerulopathy and atypical haemolytic uremic syndrome. Curr Opin Nephrol Hypertens. 2018;27(3):165-70. doi: 10.1097/MNH.0000000000000412
- Smith RJ, Appel GB, Blom AM, et al. C3 glomerulopathy – understanding a rare complement-driven renal disease. Nat Rev Nephrol. 2019;15(3):129-43. doi: 10.1038/s41581-018-0107-2
- Goodship TH, Cook HT, Fakhouri F, et al. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. Kidney Int. 2017;91(3):539-51. doi: 10.1016/j.kint.2016.10.005
- Appel GB. C3 Glomerulopathy: A New Disease Comes of Age. Mayo Clin Proc. 2018;93(8):968-9. doi: 10.1016/j.mayocp.2018.06.014
- Юрова В.А., Боброва Л.А., Козловская Н.Л., и др. Изменения в системе комплемента при мембранопролиферативном гломерулонефрите. Терапевтический архив. 2017;89(6):69-77 [Yurova VA, Bobrova LA, Kozlovskaya NL, et al. Changes in the complement system in membranoproliferative glomerulonephritis. Terapevticheskii Arkhiv (Ter. Arkh.). 2017;89(6):69-77 (in Russian)]. doi: 10.17116/terarkh201789669-77
- Marinozzi MC, Roumenina LT, Chauvet S, et al. Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN. J Am Soc Nephrol. 2017;28(5):1603-13. doi: 10.1681/ASN.2016030343
- Corvillo F, Okrój M, Nozal P, et al. Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations. Front Immunol. 2019;10:886. doi: 10.3389/fimmu.2019.00886
- Noris M, Donadelli R, Remuzzi G. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy. Pediatr Nephrol. 2019;34(8):1311-23. doi: 10.1007/s00467-018-3989-0
- Демьянова К.А., Козловская Н.Л., Боброва Л.А, и др. Сравнительный анализ изменений в системе комплемента при катастрофическом антифосфолипидном синдроме и атипичном гемолитико-уремическом синдроме. Вестник РАМН. 2017;72(1):42-52 [Demyanova KA, Kozlovskaya NL, Bobrova LA, et al. Complement System Abnormalities in Patients with Atypical Hemolytic Uremic Syndrome and Catastrophic Antiphospholipid Syndrome. Annals of the Russian Academy of Medical Sciences. 2017;72(1):42-52 (in Russian)]. doi: 10.15690/vramn769
- Ravindran A, Fervenza FC, Smith RJH, et al. C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic. Mayo Clin Proc. 2018;93(8):991-1008. doi: 10.1016/j.mayocp.2018.05.019
- Nasr SH, Valeri AM, Appel GB, et al. Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients. Clin J Am Soc Nephrol. 2009;4(1):22-32. doi: 10.2215/CJN.03480708
- Bajwa R, DePalma J, Khan T, et al. C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome: Two Important Manifestations of Complement System Dysfunction. Case Rep Nephrol Dial. 2018;8(1):25-34. doi: 10.1159/000486848.
- Pickering M, D’Agati V, Nester C, et al. C3 glomerulopathy: consensus report. Kidney Int. 2013; 84:1079-89. doi: 10.1038/ki.2013.377
- Iatropoulos P, Daina E, Curreri M, et al. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN. J Am Soc Nephrol. 2018;29(1):283-94. doi: 10.1681/ASN.2017030258.
- Volokhina E, Westra D, van der Velden T, et al. Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission. Clin Exp Immunol. 2015;181(2):306-13. doi: 10.1111/cei.12426
- Козловская Н.Л., Демьянова К.А., Кузнецов Д.В., и др. «Субклиническая» тромботическая микроангиопатия при атипичном гемолитико-уремическом синдроме: единичный случай или закономерность? Нефрология и диализ. 2014;16(2):280-7 [Kozlovskaya NL, Demyanova KA, Kuznetsov DV, et al. Atypical haemolytic uremic syndrome with ”subclinical” thrombotic microangiopathy: a single case or regularity? Nefrologiia i dializ. 2014;16(2):280-7 (in Russian)].
补充文件
